Pancreatic Cancer Research

ResearcherSecond Military Medical UniversityNo recent work listed

Ronglin Yan

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-9270-6462; OpenAlex author ID A5103192809. Sources: OpenAlex.

Their work

Papers
3 (first author 1, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
9
Papers, trials and grants by year

2016: 1 paper · 2017: 1 paper · 2018: none · 2019: none · 2020: 1 paper

Papers 3

  1. FAM84B, amplified in pancreatic ductal adenocarcinoma, promotes tumorigenesis through the Wnt/β-catenin pathway. Co-author DOI 10.18632/aging.103044↗
  2. High Expression of Cell Division Cycle 42 Promotes Pancreatic Cancer Growth and Predicts Poor Outcome of Pancreatic Cancer Patients. Last author DOI 10.1007/s10620-017-4451-z↗
  3. Deregulation of MicroRNA-375 inhibits cancer proliferation migration and chemosensitivity in pancreatic cancer through the association of HOXB3. First author PMID 27186281↗

Closest collaborators

The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Dejun Yang · 3 shared papers, 2016–2020 · strength 0.25
  2. Xin Zhang · 1 shared paper, 2020 · strength 0.11
  3. Qingping Cai · 1 shared paper, 2020 · strength 0.11
  4. Ziran Wei · 1 shared paper, 2017 · strength 0.07
  5. Yu Xin Zhang · 1 shared paper, 2017 · strength 0.07
  6. Qingping Cai · 1 shared paper, 2017 · strength 0.07
  7. Zhenxin Zhu · 1 shared paper, 2016 · strength 0.07
  8. Xin Zhang · 1 shared paper, 2016 · strength 0.07
  9. Xin Zhang · 1 shared paper, 2016 · strength 0.07

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.